Setting a Quality & Compliance Foundation for
Life Sciences Firms to Leverage Technological Advancements
LONDON, Nov. 21,
2024 /PRNewswire/ -- Hexaware Technologies, a
provider of IT services and solutions, has partnered with
Archimedis Digital to introduce Quality & Compliance as a
Solution (QCaaS). Inspired by Computerized Systems Assurance (CSA)
and powered by Artificial Intelligence (AI), this solution is
designed to assist the life science industry by ensuring quality
and cost-effectiveness without risking regulatory
compliance.
Key Features of QCaas:
- US Food and Drug Administration (FDA) CSA Inspired:
Built on the FDA CSA (Computerized Software Assurance) principles
of risk-based validation, critical thinking, and lean
documentation.
- GenAI Powered: Features a digital platform centered on
AI, with multiple GenAI-based tools to accelerate document
generation, risk analysis, and quality reviews.
- Domain Experts in the Loop: Integrates quality and
compliance experts with years of industry experience and contextual
intelligence.
- Value for Money: Reduces costs and time for verification
and validation activities, leading to faster product releases and
upgrades.
Hexaware's extensive reach, combined with Archimedis Digital's
domain expertise, aims to provide a solution for BioPharma, MedTech
companies, and allied industry segments requiring regulatory
compliance. This collaboration endeavors to address the need for
cost reduction and expedited quality processes in the life sciences
industry.
Srinivas Marimganti, Head of Life Sciences &
Healthcare, Hexaware Technologies stated:
"We are pleased to partner with Archimedis Digital in
delivering QCaaS to our broad range of life sciences clients.
This collaboration combines Hexaware's expertise in client
solutions with Archimedis Digital's domain capabilities. We're
excited to bring this capability to the industry, targeted towards
driving faster, more reliable outcomes."
Duraisamy Rajan Palani,
Founder & CEO, Archimedis Digital, added: "We have
created a Quality & Compliance framework leveraging our years
of life sciences industry experience and are in the process of
digitizing the same. We are thrilled to take this solution to
Hexaware's clients."
About Archimedis Digital
Present in the US and India and
expanding in LATAM and Europe,
Archimedis Digital builds digital products and offers services
exclusively to life sciences firms worldwide. Originating from a
business group that develops and manufactures pharmaceutical
products, Archimedis combines its deep-rooted domain expertise with
technology to build innovative solutions for the life sciences
industry. The company provides comprehensive solutions for quality
and compliance. For more information,
visit www.archimedis.io.
About Hexaware
Hexaware is a global technology and business process services
company. Every day, Hexawarians wake up with a singular purpose; to
create smiles through great people and technology. With offices
across the world, we empower enterprises worldwide to realize
digital transformation at scale and speed by partnering with them
to build, transform, run, and optimize their technology and
business processes.
"Hexaware Technologies Limited (the "Company") is
proposing, subject to receipt of requisite approvals, market
conditions and other considerations, to make an initial public
offer of its equity shares and has filed a draft red herring
prospectus dated September 6, 2024
("DRHP") with the Securities and Exchange Board of India (SEBI). The
DRHP is available on the websites of our Company, at
www.hexaware.com, SEBI at www.sebi.gov.in as well as on the
websites of the book running lead managers, Kotak Mahindra Capital
Company Limited, Citigroup Global Markets India Private Limited,
J.P. Morgan India Private Limited, HSBC Securities and Capital
Markets (India) Private Limited,
and IIFL Securities Limited, at
https://investmentbank.kotak.com,
www.online.citibank.co.in/rhtm/citigroupglobalscreen1.htm ,
www.jpmipl.com,
https://www.business.hsbc.co.in/en-gb/regulations/hsbc-securities-and-capital-market,
and www.iiflcap.com respectively, and the websites of
the stock exchange(s) at www.nseindia.com and www.bseindia.com,
respectively. Any potential investor should note that investment in
equity shares involves a high degree of risk and for details
relating to such risk, see "Risk Factors" of the RHP, when
available. Potential investors should not rely on the DRHP for any
investment decision."
Learn more about Hexaware at https://hexaware.com/
Logo:
https://mma.prnewswire.com/media/2237417/Hexaware_NEW_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/hexaware-launches-qcaas-in-partnership-with-archimedis-digital-302312641.html